The Effect of Parenteral Nutrition Supplement on Esophagectomy Patients

Status Completed

Clinical Trial Summary

Malnutrition is common in esophagus cancer patients, especially after surgery therapy. Whether parenteral supplement with enteral nutrtion is benificial for patients after esophagectomy is controversial, when compared with enteral nutrition alone. In this study, the investigators are to examine the effect of enteral nutrition supplemented with parenteral nutrtion on nutrition status after esophagectomy.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Esophagus Cancer

Clinical Trial Details

NCT number	NCT01669356
Study type	Interventional
Source	Shanghai Zhongshan Hospital
Contact
Status	Completed
Phase	N/A
Start date	July 2012
Completion date	March 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06010862` - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors	Phase 1
Completed	`NCT00201747` - Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer	Phase 2
Recruiting	`NCT06036563` - Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Not yet recruiting	`NCT05023928` - Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus Cancer	Phase 1
Recruiting	`NCT03941626` - Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies	Phase 1/Phase 2
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Recruiting	`NCT02988921` - MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy	N/A
Terminated	`NCT02797405` - Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay	N/A
Completed	`NCT02979691` - Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01	Phase 2/Phase 3
Recruiting	`NCT03347630` - Pre-operative MRI of Esophagus Cancer	N/A
Completed	`NCT00193141` - Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer	Phase 2
Recruiting	`NCT05626309` - Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer	N/A
Completed	`NCT05615129` - Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting
Recruiting	`NCT04821765` - Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer	Phase 2
Terminated	`NCT03108885` - Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Recruiting	`NCT04046575` - Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer	Phase 1
Recruiting	`NCT06126406` - Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors	Phase 1
Completed	`NCT03467529` - Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study
Completed	`NCT02552121` - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors	Phase 1/Phase 2
Completed	`NCT02001623` - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors	Phase 1/Phase 2